NHLBI's Dr. Neal Young talks about clinical trials for blood and bone marrow diseases

Office of the Director - May 18, 2012

Dr. Neal Young talks about the importance of conducting and participating in clinical trials and the difference these studies have made in the lives of people with rare blood and bone marrow diseases such as aplastic anemia.

In this video, Neal Young, M.D., chief of the Division of Intramural Research's Hematology Branch at the NHLBI, shares insight about the importance of conducting clinical trials, some of the benefits of participating in a trial, and a discovery his team made in 2011 about treating the rare blood disease aplastic anemia. The video is part of the Institute's continued efforts to share success stories about the treatment and prevention of heart, lung, and blood diseases. We hope you will watch and email, tweet, embed, Facebook, or share the video in other ways to help spread this important message to an even wider audience.

For his work to save the lives of patients with bone marrow failure diseases, including aplastic anemia, Dr. Young was recently recognized as a finalist for one of the Samuel J. Heyman Service to America Medals ("Sammies") in the Science and Environment category. Nine medals are awarded each year to "outstanding federal workers who are making high-impact contributions critical to the health, safety and well-being of Americans." The medal recipients will be announced on September 13. This nomination is in itself a rewarding recognition of his contributions and we at the NHLBI are proud of Young and our fellow colleagues for their daily dedication to advancing health.

Do you have an NHLBI-funded story to share? Let us know so we can celebrate your accomplishments: nhlbi_news@nhlbi.nih.gov.

Related links:

Twitter

Facebook

YouTube